Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Somatic Mutational Landscape in Mexican Patients: CDH1 Mutations and chr20q13.33 Amplifications Are Associated with Diffuse-Type Gastric Adenocarcinoma. | Int J Mol Sci | 2022 | 36232418 | PubTator, text mining | PubMed |
| The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer. | Front Genet | 2022 | 36226193 | PubTator, text mining | PubMed |
| Therapeutic strategies for gastric cancer targeting immune cells: Future directions. | Front Immunol | 2022 | 36225938 | PubTator, text mining | PubMed |
| Mechanism of Emodin in the Treatment of Rheumatoid Arthritis. | Evid Based Complement Alternat Med | 2022 | 36225183 | PubTator, text mining | PubMed |
Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignancies. | J Transl Med | 2022 | 36224560 | PubTator, text mining | PubMed |
| Leucine zipper protein 2 serves as a prognostic biomarker for prostate cancer correlating with immune infiltration and epigenetic regulation. | Heliyon | 2022 | 36217461 | PubTator, text mining | PubMed |
| SAFit2 reduces neuroinflammation and ameliorates nerve injury-induced neuropathic pain. | J Neuroinflammation | 2022 | 36217203 | PubTator, text mining | PubMed |
| Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma. | Front Genet | 2022 | 36212138 | PubTator, text mining | PubMed |
| B cell-T cell interplay in immune regulation: A focus on follicular regulatory T and regulatory B cell functions. | Front Cell Dev Biol | 2022 | 36211467 | PubTator, text mining | PubMed |
| A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma. | Front Immunol | 2022 | 36211401 | PubTator, text mining | PubMed |
| Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target. | Front Immunol | 2022 | 36211343 | PubTator, text mining | PubMed |
| Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma. | Front Pharmacol | 2022 | 36210802 | PubTator, text mining | PubMed |
| Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma. | Comput Intell Neurosci | 2022 | 36199963 | PubTator, text mining | PubMed |
| Identification of Downregulated Exosome-Associated Gene ENPP1 as a Novel Lipid Metabolism and Immune-Associated Biomarker for Hepatocellular Carcinoma. | J Oncol | 2022 | 36199794 | PubTator, text mining | PubMed |
| Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients. | J Transl Med | 2022 | 36195908 | PubTator, text mining | PubMed |
| Identification of distinct functional thymic programming of fetal and pediatric human γδ thymocytes via single-cell analysis. | Nat Commun | 2022 | 36195611 | PubTator, text mining | PubMed |
Reconsideration of the Role of Regulatory T Cells during Pregnancy: Differential Characteristics of Regulatory T Cells between the Maternal-Fetal Interface and Peripheral Sites and between Early and Late Pregnancy. | Med Princ Pract | 2022 | 36195068 | PubTator, text mining | PubMed |
| The Proportion of Vδ1T Cells in Peripheral Blood Correlated with Prognosis of Sepsis. | Iran J Immunol | 2022 | 36190378 | PubTator, text mining | PubMed |
| The expanding impact of T-regs in the skin. | Front Immunol | 2022 | 36189219 | PubTator, text mining | PubMed |
| Constructing a molecular subtype model of colon cancer using machine learning. | Front Pharmacol | 2022 | 36188575 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=47